Head to head
UL Solutions vs Cintas
Side-by-side on the measures that matter, with a plain-English read. Full detail: ULS · CTAS
ULS
UL Solutions
67.13-1.81%
1-year price shape — -8% over the period
Quant Rating D · 29/100
vs
CTAS
Cintas
197.19+0.63%
1-year price shape — +0% over the period
Quant Rating C · 39/100
1-year performance, rebased to 100
Cintas edges it on the scoreable measures. Cintas has the highest Quant Rating (39); Cintas has done best over the past year (+0%); Cintas pays the highest dividend yield.
| ULS | CTAS | |
|---|---|---|
| Snapshot | ||
| Sector | Specialty Business Services | Specialty Business Services |
| Last price | 67.13 | 197.19 |
| Change today | -1.81% | +0.63% |
| 1-year return | -8.0% | +0.0% |
| Market cap | $13.55B | $78.30B |
| 52-week range | 63.17 – 107.17 | 160.31 – 218.60 |
| Valuation | ||
| P/E (TTM) | 27.07 | 38.89 |
| P/E percentile, own 5-yr range | 4th | 37th |
| P/B | 8.50 | 15.04 |
| Dividend yield | 0.82% | 0.95% |
| Profitability & growth | ||
| EPS (TTM) | 1.60 | 4.91 |
| Net profit (TTM) | $323.04M | $1.95B |
| Revenue (TTM) | $3.15B | $11.56B |
| Revenue growth (YoY) | +5.2% | +10.9% |
| Gross margin | 50.4% | 51.0% |
| Operating margin | 19.0% | 23.6% |
| Net margin | 16.1% | 17.8% |
| Free cash flow (TTM) | $436.00M | $2.03B |
| Ownership & sentiment | ||
| Institutional ownership | 105.4% | 69.6% |
| Insider activity (12mo) | 45 buy / 5 sell | 37 buy / 13 sell |
| Short interest (% of float) | 2.7% | 2.8% |
| Analyst consensus | 67% buy / 33% hold (9) | 64% buy / 29% hold / 7% sell (14) |
| Analyst price target | $94 (+39%) | $225 (+14%) |
| StockVane view | ||
| StockVane Quant Rating | D (29) | C (39) |
| Company | ||
| Employees | 14,851 | 48,100 |
| Founded | 1893 | 1968 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.